The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step
- PMID: 19798756
- PMCID: PMC4083507
- DOI: 10.1002/da.20617
The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step
Erratum in
-
CORRIGENDUM.Depress Anxiety. 2019 Oct;36(10):996. doi: 10.1002/da.22951. Epub 2019 Sep 2. Depress Anxiety. 2019. PMID: 31577865 No abstract available.
References
-
- March J, Silva S, Petrycki S, et al. Treatment for Adolescents with Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. Treatment for Adolescent Depression Study (TADS) randomized controlled trial. J Am Med Assoc. 2004;292:807–820. - PubMed
-
- Bridge J, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. J Am Med Assoc. 2007;297:1683–1696. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 MH061835/MH/NIMH NIH HHS/United States
- MH61835/MH/NIMH NIH HHS/United States
- U01 MH061958/MH/NIMH NIH HHS/United States
- U01 MH061864/MH/NIMH NIH HHS/United States
- MH66371/MH/NIMH NIH HHS/United States
- MH61869/MH/NIMH NIH HHS/United States
- U01 MH061869/MH/NIMH NIH HHS/United States
- U01 MH061856/MH/NIMH NIH HHS/United States
- U01 MH062014/MH/NIMH NIH HHS/United States
- MH62014/MH/NIMH NIH HHS/United States
- MH61958/MH/NIMH NIH HHS/United States
- MH61864/MH/NIMH NIH HHS/United States
- P30 MH066371/MH/NIMH NIH HHS/United States
- MH61856/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical